'Caffeine therapy for Apnea of Prematurity' (CAP) Trial
• Caffeine reduces BPD when used within the first 10 days in preterm infants < 1250 grams (Schimdt,B et al N Engl J Med, 2006) • "The administration of positive airway pressure through an endotracheal tube, the use of any positive airway pressure, and oxygen therapy were each discontinued one week earlier for infants in the caffeine group than for infants in the placebo group" - (Schimdt,B et al N Engl J Med, 2006) • Reduced duration of mechanical ventilation vs.
• Direct pulmonary effect of caffeine
Possible mechanisms of actions of caffeine
• Caffeine decreases the pulmonary tissue expression of chemokines & leukocyte influx following hyperoxia in newborn mice (Weichelt,U et al Eur Respir J 2013) • Caffeine promotes anti-inflammatory effects in the immature lung of prenatal LPS-exposed rat pups, associated with improvement of respiratory system resistance (Koroglu,O et al Neonatology 2014) • Caffeine induces alveolar apoptosis in the hyperoxia-exposed developing mouse lung (Dayanim,S et al Pediatr Res 2014) HIF-1α 
P5

Molecular studies
• mRNA expression in the lung tissue was analyzed by qRT PCR (Quantified by 2-∆∆C(t) method)
• Data were analyzed on PCR array online web portal (SA Biosciences, MD)
• P values were calculated based on students' T test from the 2-∆∆C(t) values for each gene in the control group (room air) and the treatment group (oxygen with and without caffeine)
• Results are expressed as fold change in mRNA expression compared to RA-NS group (p<0.05 considered significant) 
